[CLDX] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- -15.01%
YoY- -29.55%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 2,009 2,433 2,434 2,363 1,952 2,516 37,721 -85.86%
PBT -13,362 -13,083 -12,294 -11,334 -9,802 -9,574 23,046 -
Tax -252 -410 268 -288 -158 -268 1,449 -
NP -13,773 -13,516 -12,732 -11,772 -10,236 -10,059 22,661 -
Tax Rate - - - - - - -6.29% -
Total Cost 15,782 15,949 15,166 14,135 12,188 12,575 15,060 3.17%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin -685.56 -555.53 -523.09 -498.18 -524.39 -399.80 60.08 -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS -3.52 -4.04 -3.81 -4.00 -4.10 -4.71 10.61 -
EPS Diluted -3.52 -4.04 -3.81 -4.00 -4.10 -4.71 10.61 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.